Quick Answer
GUIDED THERAPEUTICS INC reported Operating Income Loss of -$2.37 million for the year ending 2025.
- GUIDED THERAPEUTICS INC showed a decrease of -12.5% in Operating Income Loss from 2024 to 2025.
- This data is from GUIDED THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: -$1.60 million | Q3 2015: -$1.84 million | Q1 2016: -$1.13 million | Q2 2016: -$898.0 thousand | Q3 2016: -$679.0 thousand | Q1 2017: -$514.0 thousand | Q2 2017: -$533.0 thousand | Q3 2017: -$1.34 million | Q1 2018: -$376.0 thousand | Q2 2018: -$491.0 thousand | Q3 2018: -$234.0 thousand | Q1 2019: -$257.0 thousand | Q2 2019: -$327.0 thousand | Q3 2019: -$188.0 thousand | Q1 2020: -$242.0 thousand | Q2 2020: -$369.0 thousand | Q3 2020: -$153.0 thousand | Q1 2021: -$823.0 thousand | Q2 2021: -$561.0 thousand | Q3 2021: -$487.0 thousand | Q1 2022: -$443.0 thousand | Q2 2022: -$717.0 thousand | Q3 2022: -$1.22 million | Q1 2023: -$843.0 thousand | Q2 2023: -$1.51 million | Q3 2023: -$623.0 thousand | Q1 2024: -$359.0 thousand | Q2 2024: -$655.0 thousand | Q3 2024: -$561.0 thousand | Q1 2025: -$414.0 thousand | Q2 2025: -$763.0 thousand | Q3 2025: -$485.0 thousand.
- Over the full 16 years of available data (2010 to 2025), GUIDED THERAPEUTICS INC's Operating Income Loss has declined by 46.3%.
- Historical annual values: Fiscal year 2025: -$2.37 million | Fiscal year 2024: -$2.11 million | Fiscal year 2023: -$3.46 million | Fiscal year 2022: -$3.33 million | Fiscal year 2021: -$2.36 million | Fiscal year 2020: -$1.05 million | Fiscal year 2019: -$937.0 thousand | Fiscal year 2018: -$1.55 million | Fiscal year 2017: -$3.12 million | Fiscal year 2016: -$3.82 million | Fiscal year 2015: -$6.23 million | Fiscal year 2014: -$8.67 million | Fiscal year 2013: -$6.61 million | Fiscal year 2012: -$4.28 million | Fiscal year 2011: -$6.76 million | Fiscal year 2010: -$1.62 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: